NCT04438408View on ClinicalTrials.gov

National Survey on Care Pathway and Quality of Life in Patients With Severe Asthma According to Their Phenotype.

UnknownOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

December 1, 2021

Conditions
Asthma ChronicSevere Asthma
Interventions
OTHER

questionaires

patients will answer to questionnaires on the quality of life and the control of the asthmatic disease as well as the therapeutic observance.

Trial Locations (1)

31000

RECRUITING

UHToulouse, Toulouse

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University Hospital, Toulouse

OTHER